Commentary

In this commentary, the authors describe the hospital environment and the protective measures being taken during the COVID-19 pandemic in a hospital in Tuscany, Italy.

Read commentary on the possible reasons why placebo response rates in clinical trials for schizophrenia are increasing.

This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.

This commentary discusses the findings and implications of a recent study by Gründer et al and also highlights the importance of following formulas to estimate creatinine clearance, reading package...

This commentary discusses common decisional uncertainties surrounding antidepressant discontinuation syndrome in the clinical setting and seeks to outline a roadmap for clinicians to drive research on this important topic.

In this commentary, the authors outline differing models of antidepressant withdrawal syndromes and discuss how the model a clinician uses can impact interpretation of phenomena as well as management...